Area of research
Pulmonary and Respiratory Medicine · Emergency Medical Services
Research interest
Research interests include Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Chronic Obstructive Pulmonary Disease (COPD) Research, and Tracheal and airway disorders.
Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry.
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial.
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
Levelling the playing field through the London Network of the UK clinical trials accelerator platform
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
Bridging the “Know-Do” Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science
Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
Bronchiectasis and inhaled tobramycin: A literature review.
Whole-genome analysis of <i>Haemophilus influenzae</i> strains isolated from persons with cystic fibrosis.
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
Characterization of clinical Ralstonia strains and their taxonomic position
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis
Management of chronic <i>Pseudomonas aeruginosa</i> infection with inhaled levofloxacin in people with cystic fibrosis.
Antimicrobial resistance: Concerns of healthcare providers and people with CF.
Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult <i>β</i>ENaC-Tg Mice.
An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT
An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT
2021cited by 0position: contributor
Lung function and microbiota diversity in cystic fibrosis
Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis
Efficacy and safety of TOBI Podhaler in<i>Pseudomonas aeruginosa-</i>infected bronchiectasis patients: iBEST study
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices.
Finding the relevance of antimicrobial stewardship for cystic fibrosis.